OS Therapies Incorporated (OSTX)

NYSEAMERICAN: OSTX · Real-Time Price · USD

1.520

-0.030 (-1.94%)

At close: Mar 12, 2026, 4:00 PM EDT

1.560

+0.040 (2.63%)

Pre-market: Mar 13, 2026, 6:55 AM EDT

OS Therapies Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2022	FY 2022
Period Ending	Mar '26 Mar 12, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Cap	54	89	-	-	-	-
Market Cap Growth	51.82%	-	-	-	-	-
Enterprise Value	51.65	87.87	0	0	0	0
Last Close Price	1.52	4.28	-	-	-	-
PE Ratio	-	-4.86	-	-	-	-
PB Ratio	13.90	-27.34	-	-	-	-
P/TBV Ratio	10.46	-16.22	-	-	-	-
P/FCF Ratio	-	-12.27	-	-	-	-
P/OCF Ratio	-	-12.27	-	-	-	-
EV/EBITDA Ratio	-	-12.90	-	-	-	-
EV/EBIT Ratio	-	-12.90	-	-	-	-
EV/FCF Ratio	-	-12.07	-	-	-	-
Debt / Equity Ratio	-	0	-0.61	-0.59	-0.62	-0.93
Debt / EBITDA Ratio	-	-	-3.37	-2.33	-1.46	-1.04
Debt / FCF Ratio	-	-	-4.86	-2.73	-1.60	-2443.62
Net Debt / Equity Ratio	-0.52	1.69	-0.61	-0.58	-0.61	-0.74
Net Debt / EBITDA Ratio	0.10	0.81	-3.36	-2.29	-1.45	-0.83
Net Debt / FCF Ratio	0.15	0.76	-4.85	-2.68	-1.58	-1933.19
Quick Ratio	0.46	1.20	0.00	0.03	0.09	0.80
Current Ratio	0.56	1.20	0.03	0.08	0.09	0.80
Return on Equity (ROE)	-662.55%	76.56%	37.48%	43.12%	0.23%	95.27%
Return on Assets (ROA)	-271.66%	-215.05%	-664.43%	-1064.99%	-0.58%	-336.54%
Return on Invested Capital (ROIC)	-3817.70%	207.55%	126.92%	217.01%	1.23%	717.89%
Return on Capital Employed (ROCE)	-688.33%	59.24%	29.39%	100.95%	2.26%	1328.38%
Earnings Yield	-37.84%	-20.56%	-	-	-	-
FCF Yield	-24.07%	-8.15%	-	-	-	-
Buyback Yield / Dilution	-7.70%	-7.53%	-	-	-	-

Updated Sep 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q